Status:
COMPLETED
A Single Supplement of a Standardised Bilberry Extract Modifies Glycaemic Response
Lead Sponsor:
University of Aberdeen
Conditions:
Type 2 Diabetes
Eligibility:
MALE
40-70 years
Phase:
NA
Brief Summary
Dietary strategies for alleviating health complications associated with type 2 diabetes (T2D) are being pursued as alternatives to pharmaceutical interventions. Berries such as bilberries that are ric...
Detailed Description
Dietary strategies for alleviating health complications, such as premature vascular disease, associated with type 2 diabetes (T2D) and obesity are actively being pursued as alternatives to pharmaceuti...
Eligibility Criteria
Inclusion
- Male subjects
- Aged \>40 and \<70
- Clinical diagnosis of Type 2 diabetes controlling their diabetes by diet alone
- All subjects must live in the Aberdeenshire area of Scotland
Exclusion
- Medical exclusion criteria
- Clinical diagnosis of thromboembolic or coagulation disease
- Clinical diagnosis of unregulated thyroid disease
- Clinical diagnosis of kidney disease
- Clinical diagnosis of severe gastrointestinal disorders
- History of Alcohol or any other substance abuse
Key Trial Info
Start Date :
September 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2013
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT01245270
Start Date
September 1 2010
End Date
August 1 2013
Last Update
March 10 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Aberdeen Rowett Institute of Nutrition and Health
Aberdeen, United Kingdom, AB21 9SB